September 15, 2021 -- Cell programming company Ginkgo Bioworks will go public after it finalizes a $1.6 billion deal with Soaring Eagle Acquisition, a special purpose acquisition company (SPAC).
The deal was approved by Soaring Eagle's shareholders on September 14. Subject to customary closing conditions, Soaring Eagle anticipates that the deal with Gingko will close on September 16. Following closing, Soaring Eagle will change its name to Ginkgo Bioworks Holdings.
The combined company's shares of class A common stock and public warrants are expected to begin trading on the New York Stock Exchange on September 17, 2021, under the ticker symbols DNA and DNA.WS, respectively.